One-quarter of older advanced cancer patients taking eight or more drugs
Mar 20, 2023
Polypharmacy was tied to an increased risk for adverse treatment outcomes, such as toxicity and early treatment discontinuation.
FDA advisers back full approval of Paxlovid
Mar 17, 2023
The panel of FDA advisers says that the medication remains safe and effective for high-risk patients.
AAOS: Patients aged ≥75 years report better pain relief than younger patients
Mar 15, 2023
Patients aged 75 years and older saw better pain relief and improved quality of life compared with patients younger than 55 years.
Yoga may improve markers of frailty in older adults
Mar 14, 2023
Some clinically meaningful improvements were seen compared with education or inactive control.
Long-term PM₂.₅ exposure linked to increased risk for cardiovascular events
Mar 13, 2023
An increased risk for incident acute myocardial infarction, ischemic heart disease mortality and cardiovascular disease mortality was seen with exposure to PM2.5 at moderate versus low concentrations.
Atrial fibrillation may increase risk for dementia
Mar 10, 2023
The risk was more prominent in younger patients and those without chronic kidney disease.
Minimal change in mental health linked to COVID-19
Mar 09, 2023
In general population studies, no change was observed in general mental health or anxiety symptoms; minimal worsening was seen in depression symptoms.
Frequent social activity tied to longer survival in older adults
Mar 09, 2023
A threshold effect was seen with meaningful benefit for participating in social activity almost every day.
Air pollution exposure tied to bone loss in postmenopausal women
Mar 08, 2023
The findings were particularly strong between nitrogen oxides exposure and lumbar spine density.
FDA panel to again weigh merit of decongestant that many call useless
Mar 06, 2023
The agency’s Nonprescription Drugs Advisory Committee will meet in April to consider the effectiveness of the oral version of phenylephrine.